trial

Plan D- Vitamin D Supplementation in Psychotic Disorders

NCTId NCT05211635
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 14 (actual)
Sponsored by University Hospital, Akershus
Primary completion 2025-01-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
14 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2022-04-04
Primary completion
2025-01-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Vitamin D

Sponsors

University Hospital, AkershusLead Sponsor
University of OsloCollaborator
Oslo University HospitalCollaborator

Investigators

1
Mari Nerhus, PhDPrincipal Investigator

Sites

1 total
Lørenskog, Norway

Facts & assertions

4 sourced
Enrollment
14
Phase
NA
Primary Completion Date
2025-01-01
Status
COMPLETED
relationships
The graph out of here
drug
Vitamin D
drug
lead_sponsor
University Hospital, Akershus
company
collaborator
University of Oslo
company
Oslo University Hospital
company
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
Schizophrenia Spectrum and Other Psychotic Disorders
indication
investigator
Mari Nerhus, PhD
person